{"resourceType":"Observation","id":"1b73db9b-89b4-5630-bbdc-f28610d9ec81","meta":{"versionId":"1","lastUpdated":"2022-05-24T15:15:12.496-04:00","source":"#JrzabU3ukrw7DgOk","profile":["http://fhir.mimic.mit.edu/StructureDefinition/mimic-observation-micro-test"]},"identifier":[{"system":"http://fhir.mimic.mit.edu/identifier/observation-micro-test","value":"6028147-90134"}],"status":"final","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/observation-category","code":"laboratory"}]}],"code":{"coding":[{"system":"http://fhir.mimic.mit.edu/CodeSystem/microbiology-test","code":"90134","display":"EPSTEIN-BARR VIRUS VCA-IgM AB"}]},"subject":{"reference":"Patient/0a8eebfd-a352-522e-89f0-1d4a13abdebc"},"effectiveDateTime":"2180-03-23T11:51:00-04:00","valueString":"NEGATIVE <1:10 BY IFA.  INTERPRETATION: RESULTS INDICATIVE OF PAST EBV INFECTION.  In most populations, 90% of adults have been infected at sometime with EBV and will have measurable VCA IgG and EBNA antibodies. Antibodies to EBNA develop 6-8 weeks after primary infection and remain present for life. Presence of VCA IgM antibodies indicates recent primary infection.  ","specimen":{"reference":"Specimen/90e25d88-bb8a-50b2-947c-18b07f998d8a"}}